Brett Sandercock - 11 Oct 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
11 Oct 2021
Transactions value $
-$1,122,450
Form type
4
Filing time
12 Oct 2021, 18:57:56 UTC
Previous filing
13 Sep 2021
Next filing
12 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $144K +2.5K +2.86% $57.76 89.8K 11 Oct 2021 Direct F1
transaction RMD ResMed Common Stock Sale -$1.27M -5K -5.57% $253.37 84.8K 11 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -2.5K -9.09% $0.00 25K 11 Oct 2021 ResMed Common Stock 2.5K $57.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.